The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Brain Cancer Research Investigator Grant
This award is presented annually by B*CURED to a clinical doctor or research scientist whose primary focus is brain cancer research. Clinical projects are encouraged, as well as translational projects with significant clinical promise. Projects for adult and pediatric brain cancer research will be considered.
The term of the grant is one year. The award will be for $50,000 and will be given in two installments. The first installment of $25,000 will be paid to the winner by June 15, 2019. The second installment of $25,000 will be paid 6 months later, once a satisfactory progress report (3 pages) is submitted to and reviewed by the B*CURED Medical Advisory Board. This progress report will be due exactly 6 months from the initial funding date. A final (3 page) summary report is required from the grant winner exactly one year from the date of funding.
The research project must be directly related to the field of brain cancer. The award will be given to the applicant exclusively for the purpose of conducting the proposed research. All proposed research must have appropriate Institutional Review Board approval for clinical projects before funding is granted. The winner’s name, institution, title of the research project, and a brief description of the project in layman’s terms will be posted on the B*CURED website.
Application Deadline: April 1, 2020
Applicants must be faculty at a research institution in North America who are:
• Undertaking clinical or translational research, with the intention of applying for R01 NIH funding or the equivalent within 5 years, or
• Undertaking innovative research to bridge from bench to animal research or to acquire preclinical data from animal models.
Applicants will compose an outstanding research proposal (5 pages maximum) that demonstrates relevance, sound methodological design, and feasibility. Formal involvement of a biostatistician is required for all clinical trial proposals, but is not required for pre-clinical or translational science proposals.